1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,830 | 3,975 | 11.11. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SELVITA Aktie jetzt für 0€ handeln | |||||
| 21.05. | Selvita S.A.: Selvita reports Q1 2026 results and launches strategic options review | 399 | PR Newswire | KRAKÓW, Poland, May 21, 2026 /PRNewswire/ -- Selvita S.A. (WSE: SLV), one of the leading Drug Discovery and Development organizations in Europe, has published its... ► Artikel lesen |
1 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| STRYKER | 288,50 | -0,65 % | Stryker: 179-Millionen-Verkauf - was Anleger wissen müssen | ||
| PALATIN TECHNOLOGIES | 7,170 | +2,72 % | This Palatin Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday | ||
| VIKING THERAPEUTICS | 25,800 | +0,39 % | Eli Lilly Just Raised Its 2026 Sales Forecast to as Much as $92 Billion. But Is Viking Therapeutics the Next Big Obesity Winner? | ||
| COSCIENS BIOPHARMA | 5,200 | 0,00 % | XFRA ET80: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| HALOZYME THERAPEUTICS | 89,32 | -3,19 % | Halozyme Therapeutics, Inc.: U.S. FDA Approves RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) Co-Formulated with Halozyme's ENHANZE Technology for the Treatment of Advanced Head and Neck Cancer | Approval extends RYBREVANT FASPRO's well-established, dual-targeted benefit beyond lung cancer SAN DIEGO, Nov. 6, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) (Halozyme) today announced... ► Artikel lesen | |
| ABCELLERA BIOLOGICS | 11,340 | +1,43 % | StoneX raises AbCellera Biologics stock price target to $15 | ||
| GLOW LIFETECH | 0,016 | -5,88 % | Smallcap Discoveries: Glow Lifetech Corp. to Present at the Annual Smallcap Discoveries Conference in Vancouver | Toronto, Ontario--(Newsfile Corp. - September 24, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that it will be participating in... ► Artikel lesen | |
| BIO-RAD LABORATORIES | 343,60 | -0,81 % | Bio-Rad reaffirms 2026 currency-neutral revenue growth at (-3%) to 0.5% while targeting non-GAAP operating margin in upper half of 10% to 12% range | ||
| AVID BIOSERVICES | - | - | Avid Bioservices Appoints Maria Ebro Andreasen as Chief People Officer to Fuel Continued Growth and Talent Strategy | Company expands team, university partnerships, and internship programs to build long-term biologics talent pipeline.TUSTIN, Calif., May 18, 2026 /PRNewswire/ -- Avid Bioservices, a leading... ► Artikel lesen | |
| BIOLINERX | 1,110 | -10,48 % | BioLineRx Ltd.: BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update | - Second of five planned cohorts ongoing in Phase 1/2a trial of GLIX1 in GBM; third patient cohort expected to commence dosing in September -
- Announced new data... ► Artikel lesen | |
| MINERVA NEUROSCIENCES | 2,138 | -0,28 % | Minerva Neurosciences, Inc. - 10-Q, Quarterly Report | ||
| WHITEHAWK THERAPEUTICS | 2,700 | -0,74 % | Whitehawk Therapeutics, Inc.: Whitehawk Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights | On track to report initial Phase 1 data from HWK-007 and HWK-016 in 1H'27Initiated Phase 1 trial for HWK-206 in the U.S., the third Whitehawk program to enter the clinic in the last 12 months; HWK-206... ► Artikel lesen | |
| INNOVENT BIOLOGICS | 10,110 | +1,00 % | Abnehmpillen-Boom: Aktie im Plus: Eli Lilly gelingt ein wichtiger Durchbruch | © Foto: Sascha Lotz/dpaEli Lilly sichert sich einen Vorsprung in China. Mit einer neuen Abnehmpille greift der US-Konzern einen Milliardenmarkt an und setzt Novo Nordisk unter Druck Enthaltene Werte:... ► Artikel lesen | |
| OVID THERAPEUTICS | 2,520 | +0,80 % | Ovid Therapeutics GAAP EPS of -$0.10 misses by $0.02 | ||
| GEOVAX LABS | 0,111 | -0,18 % | EQS-News: GeoVax, Inc.: GeoVax Announces 1-for-24 Reverse Stock Split to Regain Compliance With Nasdaq Minimum Bid Requirement | EQS-News: GeoVax, Inc.
/ Key word(s): Financial
GeoVax Announces 1-for-24 Reverse Stock Split to Regain Compliance With Nasdaq Minimum Bid Requirement 09.11.2026 / 14:30 CET/CEST
The... ► Artikel lesen |
SELVITA SA gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 3,645 Euro und damit -0,27 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SELVITA SA finden Sie auf Wallstreet Online.